| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |